학술논문
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
Document Type
Article
Author
Source
In: The Lancet Haematology . (The Lancet Haematology, April 2024, 11(4):e287-e298)
Subject
Language
English
ISSN
23523026